Clinical trials
Terminated Phase 1 trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 1 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 10 |
| Bayer | 2 |
| Copenhagen University Hospital at Herlev | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Ferring Pharmaceuticals | 2 |
| Incyte Corporation | 2 |
| AbbVie | 1 |
| Anaveon AG | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Colorectal Neoplasms | 3 |
| Small Cell Lung Carcinoma | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Cholangiocarcinoma | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.